![John Pottage](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Pottage
Director/Board Member at
SPERO THERAPEUTICS, INC.
Net worth: 165 750 $ as of 30/06/2026
Profile
John C.
Pottage is currently Director at Global Virus Network since 2022, Director at Spero Therapeutics, Inc. since 2018, and Member-Global Safety Board at MMV Medicines for Malaria Venture.
Former positions include Director at Pardes Biosciences, Inc. from 2022 to 2023, SVP, Chief Scientific & Medical Officer at ViiV Healthcare Ltd. from 2009 to 2019, SVP & Head-Infectious Disease Medicine Development at GlaxoSmithKline LLC from 2008 to 2009, Chief Medical Officer & Senior Vice President at Achillion Pharmaceuticals, Inc. from 2002 to 2007, Medical Director at Vertex Pharmaceuticals (Canada), Inc. from 1998 to 2002, Associate Professor at Rush Medical College, and a role at Coopers & Lybrand LLP in 2004.
Education includes undergraduate studies at Colgate University and a doctorate from Saint Louis University School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 23/06/2026 | 75,000 ( 0.13% ) | 165 750 $ | 30/06/2026 |
John Pottage active positions
| Companies | Position | Start |
|---|---|---|
| SPERO THERAPEUTICS, INC. | Director/Board Member | 01/09/2018 |
Global Virus Network
 Global Virus Network Miscellaneous Commercial ServicesCommercial Services Researches on essential and critical defense against viral disease | Director/Board Member | 03/05/2022 |
MMV Medicines for Malaria Venture
 MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services Develops antimalarial drugs | Corporate Officer/Principal | - |
Former positions of John Pottage
| Companies | Position | End |
|---|---|---|
| PARDES BIOSCIENCES, INC. | Director/Board Member | 30/08/2023 |
ViiV Healthcare Ltd.
 ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Chief Tech/Sci/R&D Officer | 01/10/2019 |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Corporate Officer/Principal | 01/11/2009 |
| ACHILLION PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 14/05/2007 |
Vertex Pharmaceuticals (Canada), Inc.
 Vertex Pharmaceuticals (Canada), Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of medicines for treating life threatening diseases | Chief Tech/Sci/R&D Officer | 01/05/2002 |
Training of John Pottage
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
58
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Achillion Pharmaceuticals, Inc.
 Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes treatments for infectious diseases | Health Technology |
Colgate University
 Colgate University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MMV Medicines for Malaria Venture
MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services Develops antimalarial drugs | Commercial Services |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Spero Therapeutics, Inc.
 Spero Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of bacterial infections | Health Technology |
Rush Medical College
 Rush Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Global Virus Network
Global Virus Network Miscellaneous Commercial ServicesCommercial Services Researches on essential and critical defense against viral disease | Commercial Services |
Saint Louis University School of Medicine
 Saint Louis University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vertex Pharmaceuticals (Canada), Inc.
Vertex Pharmaceuticals (Canada), Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development of medicines for treating life threatening diseases | Commercial Services |
Pardes Biosciences, Inc.
 Pardes Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops oral antiviral treatment for COVID-19 | Health Technology |
- Stock Market
- Insiders
- John Pottage
